Filing Details
- Accession Number:
- 0001144204-11-020631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-07 09:58:55
- Reporting Period:
- 2011-04-06
- Filing Date:
- 2011-04-07
- Accepted Time:
- 2011-04-07 09:58:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1059784 | Generex Biotechnology Corp | GNBT | Pharmaceutical Preparations (2834) | 820490211 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1229529 | Mark Fletcher | 33 Harbour Square Suite 102 Toronto Ontario Canada A1 M5J2G2 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-06 | 20,000 | $0.24 | 286,077 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
